BioCentury | Jan 19, 2018
Company News

Capricor and Cedars-Sinai expand cardiosphere deal

...cells. This year, Capricor plans to start a trial to test its CDC-derived exosome therapy CAP-2003...
...Capricor Therapeutics Inc. (NASDAQ:CAPR), Beverly Hills, Calif. Cedars-Sinai Medical Center, Los Angeles, Calif. Business: Cardiovascular Allison Johnson CAP-1002 CAP-2003 Capricor...
BioCentury | May 12, 2017
Clinical News

Capricor stem cell therapy misses heart repair endpoint

...month. Capricor has also studied use of exosomes in regenerative medicine, including preclinical development of CAP-2003...
...million in cash at YE16, and raised $3.7 million in a private placement this week. Paul Bonanos CAP-1002 CAP-2003 Capricor...
Items per page:
1 - 2 of 2